Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)

Agency: National Institutes of Health
NAICS: 541380 - Testing Laboratories and Services
Posted: 2023-08-24
Deadline: 2027-01-07

Matchawards

To use the MatchAwards web application, please enable JavaScript. Alternatively, try one of the native apps for MatchAwards for your platform.